We are live on !
Find out more
Squarepoint Portfolio holdings
AUM
$90.5B
Turnover
34.18%
1-Year Est. Return
33.95%
This Fund
S&P 500
This Quarter Est. Return
+23.44%
1 Year Est. Return
+33.95%
3 Year Est. Return
+77.62%
5 Year Est. Return
+56.06%
10 Year Est. Return
+196.47%
AUM
$90.5B
AUM Growth
+$5.41B
(+6.4%)
Cap. Flow
-$1.73B
Cap. Flow % of AUM
Cap. Flow %
-1.91%
Top 10 Holdings %
Top 10 Hldgs %
20.12%
Holding
5,141
New
939
Increased
1,573
Reduced
1,769
Closed
818
Avg Time Held
Equity + Options
1.7
years
Top 10 Avg Time Held
Equity + Options
0.9
years
Top 20 Avg Time Held
Equity + Options
1.1
years
Avg Time Held Equity only
1.4
years
Top 10 Avg Time Held Equity only
1.2
years
Top 20 Avg Time Held Equity only
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$732M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$553M |
| 3 |
Applied Materials
AMAT
|
+$327M |
| 4 |
Intuit
INTU
|
+$320M |
| 5 |
Chevron
CVX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$651M |
| 3 |
Microsoft
MSFT
|
+$344M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$298M |
| 5 |
Qualcomm
QCOM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.2% |
| 2 | Technology | 14.41% |
| 3 | Healthcare | 5.76% |
| 4 | Consumer Discretionary | 5.56% |
| 5 | Financials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2901
PUT
Rubrik
RBRK
$25B
| $955K | ﹤0.01% |
11,900
-52,900
| -82% | -$3.33M |
2024 Q4
6 quarters
|
|
2902
DaVita
DVA
$11.9B
| $955K | ﹤0.01% |
4,293
-96,104
| -96% | -$17.5M |
2023 Q2
12 quarters
|
|
2903
iShares Core MSCI International Developed Markets ETF
IDEV
$33.3B
| $953K | ﹤0.01% |
10,704
-19,685
| -65% | -$1.74M |
2026 Q1
1 quarter
|
|
2904
LSI Industries
LYTS
$743M
| $952K | ﹤0.01% |
35,834
-39,562
| -52% | -$914K |
2024 Q2
8 quarters
|
|
2905
PepGen
PEPG
$187M
| $952K | ﹤0.01% |
529,083
+382,487
| +261% | +$622K |
2025 Q4
2 quarters
|
|
2906
PUT
Amcor
AMCR
$21.4B
| $949K | ﹤0.01% |
+21,900
| New | +$869K |
2026 Q2
0 quarters
|
|
2907
H&R Block
HRB
$6.13B
| $949K | ﹤0.01% |
24,921
-783,841
| -97% | -$27.3M |
2025 Q3
3 quarters
|
|
2908
PUT
Amkor Technology
AMKR
$9.7B
| $949K | ﹤0.01% |
+11,000
| New | +$784K |
2026 Q2
0 quarters
|
|
2909
PUT
Wabtec
WAB
$46.7B
| $944K | ﹤0.01% |
3,500
+500
| +17% | +$132K |
2026 Q1
1 quarter
|
|
2910
XPeng
XPEV
$8.69B
| $943K | ﹤0.01% |
71,246
+37,166
| +109% | +$589K |
2025 Q4
2 quarters
|
|
2911
Snap
SNAP
$10.7B
| $941K | ﹤0.01% |
+211,968
| New | +$1.16M |
2026 Q2
0 quarters
|
|
2912
HDFC Bank
HDB
$115B
| $941K | ﹤0.01% |
36,413
-873,163
| -96% | -$21.9M |
2024 Q1
9 quarters
|
|
2913
Assembly Biosciences
ASMB
$413M
| $940K | ﹤0.01% |
34,214
+10,410
| +44% | +$283K |
2026 Q1
1 quarter
|
|
2914
IDEAYA Biosciences
IDYA
$3.49B
| $940K | ﹤0.01% |
25,218
-74,060
| -75% | -$2.27M |
2026 Q1
1 quarter
|
|
2915
AerSale
ASLE
$224M
| $940K | ﹤0.01% |
148,674
+13,417
| +10% | +$87.7K |
2024 Q4
6 quarters
|
|
2916
CALL
Symbotic
SYM
$5.24B
| $939K | ﹤0.01% |
20,900
| – | – |
2025 Q3
3 quarters
|
|
2917
Supernus Pharmaceuticals
SUPN
$2.45B
| $939K | ﹤0.01% |
20,183
-5,341
| -21% | -$257K |
2024 Q3
7 quarters
|
|
2918
Vertex
VERX
$2.49B
| $938K | ﹤0.01% |
+81,665
| New | +$1.02M |
2026 Q2
0 quarters
|
|
2919
PUT
Praxis Precision Medicines
PRAX
$7.23B
| $937K | ﹤0.01% |
2,800
+1,800
| +180% | +$570K |
2026 Q1
1 quarter
|
|
2920
M-tron Industries
MPTI
$286M
| $937K | ﹤0.01% |
+9,448
| New | +$752K |
2026 Q2
0 quarters
|
|
2921
AMERISAFE
AMSF
$493M
| $936K | ﹤0.01% |
27,654
+9,949
| +56% | +$315K |
2026 Q1
1 quarter
|
|
2922
Estee Lauder
EL
$39B
| $935K | ﹤0.01% |
11,842
+5,270
| +80% | +$426K |
2023 Q2
12 quarters
|
|
2923
Mativ Holdings
MATV
$676M
| $935K | ﹤0.01% |
123,499
-114,117
| -48% | -$983K |
2024 Q3
7 quarters
|
|
2924
CALL
Stellantis
STLA
$12.4B
| $934K | ﹤0.01% |
162,700
-167,100
| -51% | -$1.24M |
2023 Q1
13 quarters
|
|
2925
Nuvation Bio
NUVB
$1.65B
| $933K | ﹤0.01% |
164,211
+39,267
| +31% | +$192K |
2026 Q1
1 quarter
|
|
Similar funds
Squarepoint's Q2 2026 Portfolio in Review
As of Q2 2026, Squarepoint held 5,141 positions worth $90.5B, up 6.4% from $85.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Squarepoint's Q2 2026 filing shows 939 new, 1,573 increased, 1,769 reduced and 818 closed positions. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 4,852,366 shares worth $520M. The largest sale was iShares Core S&P 500 ETF, an estimated $3.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.
- Squarepoint's largest Q2 2026 buy was State Street Communication Services Select Sector SPDR ETF: 4,852,366 shares worth $520M.
- Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $732M increase.
- Squarepoint's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $3.03B.
- Squarepoint fully exited VanEck Semiconductor ETF in Q2 2026, selling an estimated $192M.
- Squarepoint's ten largest holdings make up 20% of its $90.5B portfolio in Q2 2026.
- Squarepoint opened 939 new positions and closed 818 in Q2 2026.
- Squarepoint's portfolio value rose 6.4% quarter-over-quarter to $90.5B.
Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.